Gelteq Restricted (NASDAQ: GELS) is a healthcare firm specializing within the improvement and manufacturing of edible gel merchandise, with a give attention to areas like prescription drugs, nutraceuticals, pet care, and sports activities vitamin. The corporate’s gel-based oral drug supply system is designed to boost the administration of medicines and vitamins, addressing points like dysphagia and tablet fatigue.
In an electronic mail dialog with AlphaStreet, Nathan Givoni, Gelteq’s CEO and co-founder, and Simon Szewach, govt chairman and co-founder, mentioned varied points of the enterprise.
When founding Gelteq, what market wants have been you aiming to satisfy together with your gel-based oral drug supply system?
The gel-based oral drug supply system was developed initially to help in making it simpler for the aged to eat bigger volumes of their required vitamins in a concentrated type, that was additionally each simpler to swallow and tasted higher.
Gelteq has been constantly evolving to develop our purposes and audiences. Our customizable expertise can cater to these with dysphagia, kids, adults, seniors, and even animals. Gelteq is extremely complete and versatile, protecting each the human and animal markets for nutraceuticals, prescription drugs, and different meals choices.
Are you able to make clear the vital milestones and achievements Gelteq has reached to date?
Our greatest milestone up to now has been finishing our current IPO on Nasdaq in October 2024 below the ticker GELS. Since finishing the IPO, the corporate has continued to execute on its plans, together with placing 400,000 items into manufacturing and hiring our first US-based govt to start our scale-up of U.S. operations. Wholesome Extracts, our largest U.S. buyer, additionally elevated its preliminary buy order of Gelteq collagen and Mynus sugar blocker gels by 50%, citing excessive demand and recognition of the merchandise. The FDA additionally accredited our suitability petition for a brand new animal drug below improvement. From a scientific perspective, we’ve got employed our first Chief Scientific Officer, together with lodging extra scientific patents which permits progress and evolution of the product whereas securing our expertise.
What are the principle challenges the corporate has confronted in bringing its merchandise to market, and the way did you overcome them?
One of many largest challenges we confronted as an organization was having too many product concepts and prioritizing what we may work on. Employees have been getting unfold too skinny and it was limiting the precise merchandise that we have been in a position to full and ship. Now we have discovered extensively from this and have put in place higher qualification and improvement techniques to handle every challenge. Now we have additionally expanded our group and positioned folks on particular verticals and initiatives and given them possession. This new course of has elevated effectivity which enabled extra merchandise to be market-ready and out there on the market, as proven by the 400,000 items in manufacturing now.
Are you able to focus on your long-term targets and the place you see Gelteq 5 years from now?
We imagine our gel-based drug supply system is revolutionary within the drug supply house and imagine that is the place we are going to see phenomenal progress within the subsequent 5 years. As FDA approvals are hopefully granted and extra of Gelteq’s gel-based drug merchandise are launched into the market through pharmaceutical purchasers, we anticipate there shall be a quick shift to undertake our expertise. By fixing the problems of dysphagia and tablet fatigue, Gelteq gives a system that can meet the wants of the folks impacted. Inside 5 years, we anticipate to see pharmaceutical and veterinarian cabinets having a piece devoted to gel-based drug merchandise, identical to they’ve for capsules, capsules, and gummies.
We may even be frequently engaged on new alternatives and evolving the expertise and imagine that in 5 years, our expertise may have been included into many different merchandise extensively out there throughout the nutraceutical and meals sectors for each people and animals.
What are the upcoming merchandise and improvements Gelteq is at the moment engaged on?
Gelteq continues to be an innovator within the gel supply house. We’re engaged on new merchandise throughout the nutraceutical, pet, and sports activities verticals, and we are going to proceed to launch a variety of merchandise which might be out there for purchasers to white label and have on cabinets in a matter of months. As this occurs, we’re persevering with to work with shopper requests for growing new gel-based merchandise for his or her present ranges of capsules, capsules, powders, and gummies. Our near-term initiatives are centered on the nutraceutical house, with FDA approvals wanted to drive new pharmaceutical merchandise in our gel base hopefully arriving by late 2025.
